VNDA Vanda Pharmaceuticals Inc.

8-K Current Report

Filed: March 10, 2026

Health Care

Pharmaceutical Preparations

Vanda Pharmaceuticals Inc. (VNDA) 8-K current report filed with SEC EDGAR on March 10, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

Item 7.01: Regulation FD Disclosure

AI Filing Analysis
8-K

Item 7.01 · Regulation FD Disclosure

• Vanda Pharmaceuticals filed a Reg FD disclosure (Item 7.01), signaling a potentially market-moving communication to investors
• No substantive disclosure content included in this section — material information likely contained in an accompanying exhibit

+1 more insights

Other Vanda Pharmaceuticals Inc. 8-K Filings

8-K Feb 23, 2026

Get deeper insights on Vanda Pharmaceuticals Inc.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.